logo
Product categories

EbookNice.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link.  https://ebooknice.com/page/post?id=faq


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookNice Team

Talazoparib plus enzalutamide in men with metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial by Prof Neeraj Agarwal MD & Prof Arun A Azad MD & Joan Carles MD & Prof André P Fay MD & Nobuaki Matsubara MD & Prof Cezary Szczylik MD & Ugo De Giorgi MD & Prof Jae Young Joung MD & Prof Peter C C Fong MD & Eric Voog MD & Prof Robert J Jones MBChB &... instant download

  • SKU: EBN-239573230
Zoomable Image
$ 32 $ 40 (-20%)

Status:

Available

4.6

32 reviews
Instant download (eBook) Talazoparib plus enzalutamide in men with metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial after payment.
Authors:Prof Neeraj Agarwal MD & Prof Arun A Azad MD & Joan Carles MD & Prof André P Fay MD & Nobuaki Matsubara MD & Prof Cezary Szczylik MD & Ugo De Giorgi MD & Prof Jae Young Joung MD & Prof Peter C C Fong MD & Eric Voog MD & Prof Robert J Jones MBChB &...
Pages:updating ...
Year:2025
Publisher:x
Language:english
File Size:1.06 MB
Format:pdf
Categories: Ebooks

Product desciption

Talazoparib plus enzalutamide in men with metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial by Prof Neeraj Agarwal MD & Prof Arun A Azad MD & Joan Carles MD & Prof André P Fay MD & Nobuaki Matsubara MD & Prof Cezary Szczylik MD & Ugo De Giorgi MD & Prof Jae Young Joung MD & Prof Peter C C Fong MD & Eric Voog MD & Prof Robert J Jones MBChB &... instant download

The Lancet, 406 (2025) 447-460. doi:10.1016/S0140-6736(25)00684-1
*Free conversion of into popular formats such as PDF, DOCX, DOC, AZW, EPUB, and MOBI after payment.

Related Products